Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease

The increased prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide is particularly worrisome, as no medication has been approved to treat the disease. Lifestyle modifications aimed at promoting weight loss and weight maintenance remain the current first-line treatment for NAFLD. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Run, Gu, Yunpeng, Zhang, Binbin, Kong, Tingting, Zhang, Wei, Li, Jie, Shi, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132718/
https://www.ncbi.nlm.nih.gov/pubmed/36854062
http://dx.doi.org/10.14309/ctg.0000000000000575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132718/
https://www.ncbi.nlm.nih.gov/pubmed/36854062
http://dx.doi.org/10.14309/ctg.0000000000000575

Ejemplares similares